Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Journal of the American Society of Nephrology : JASN（2023）
摘要
This article contains a podcast at.
更多查看译文
关键词
MoCA,double-blind method,empagliflozin,gait disturbance,hyponatremia,neurocognitive deficits,sodium-glucose cotransporter 2,treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要